Company Data
Merus N.V.
Ticker
MRUS
Current Price
$50.8 -7.87%
Market Cap
$3.5B
Price Target
Refer to Report
Volume
2.7M
52wk Range
$33.19 - $61.61
Overview
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics. Merus operates in one reportable segment, which comprises the discovery and development of innovative bispecific therapeutics.